Voltar
Artigo Acesso aberto Revisado por pares
BIBTEX RIS

Diabetes, antidiabetic medications, and pancreatic cancer risk: an analysis from the International Pancreatic Cancer Case-Control Consortium

2014; Elsevier BV; Volume: 25; Issue: 10 Linguagem: Inglês

10.1093/annonc/mdu276

ISSN

1569-8041

Autores

Cristina Bosetti, Valentina Rosato, D. Li, Debra T. Silverman, Gloria M. Petersen, Paige M. Bracci, Rachel Ε. Neale, Joshua Muscat, Kristin E. Anderson, Steven Gallinger, Sara H. Olson, Anthony B. Miller, H. Bas Bueno-de-Mesquita, Ghislaine Scélo, Vladimí­r Janout, Ivana Holcátová, Παγώνα Λάγιου, Diego Serraino, Ersilia Lucenteforte, Eleonóra Fabiánová, Peter Baghurst, Witold Zatoński, Lenka Foretová, Elizabeth T. H. Fontham, William R. Bamlet, Elizabeth A. Holly, Eva Negri, Moustapha Hassan, Anna E. Prizment, Michelle Cotterchio, Sean P. Cleary, Robert C. Kurtz, Patrick Maisonneuve, Dimitrios Trichopoulos, Jerry Polesel, Eric J. Duell, P. Boffetta, Carlo La Vecchia, P Ghadirian,

Tópico(s)

Cancer-related Molecular Pathways

Referência(s)